Related Experiment Video
Updated: Dec 31, 2025

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
Published on: May 25, 2018
Context-Dependent Strategies for Enhanced Genome Editing of Genodermatoses
Oliver Patrick March1, Thomas Kocher1, Ulrich Koller1
1EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.
Genome editing offers new genetic therapies for genodermatoses, a group of inherited skin disorders. Selecting the optimal genome editing strategy based on mutation and disease context is crucial for clinical success.
Area of Science:
- Dermatology
- Genetics
- Molecular Biology
Background:
- Genodermatoses are inherited skin disorders caused by gene mutations, significantly impairing skin barrier function.
- Current treatments, like for epidermolysis bullosa, mainly focus on wound management.
- Genome editing technologies offer potential for novel genetic therapies by correcting specific DNA sequences.
Purpose of the Study:
- To review current genome editing approaches for treating genodermatoses.
- To discuss optimal genome editing strategies tailored to specific genetic contexts and diseases.
- To advance the development of efficient genome editing therapies for inherited skin disorders.
Main Methods:
- Review of current genome editing technologies and their application to genodermatoses.
- Analysis of mutation, gene, and disease context for strategy selection.
- Discussion of challenges and future directions for clinical implementation.
Main Results:
- Multiple genome editing strategies can address phenotypes associated with various genodermatosis mutations.
- The choice of genome editing approach should be guided by the specific genetic and disease context.
- Efficient and context-specific genome editing is necessary for successful clinical translation.
Conclusions:
- Genome editing holds significant promise for treating debilitating genodermatoses.
- Tailoring genome editing strategies to individual genetic contexts is key to therapeutic success.
- Further research and development are needed to optimize genome editing for widespread clinical application.
More Related Videos
Related Concept Videos
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Homologous Recombination
CRISPR/Cas9 Genome Editing
CRISPR
In-vitro Mutagenesis

